1. Introduction {#sec1}
===============

In the research of biologically active molecules, free radicals have been linked to several degenerative diseases including neurodegenerative and cardiovascular disorder, atherosclerosis and cancer ([@bib1]). Although the discovery of antioxidant compounds has been an area widely studied ([@bib15]; [@bib6]; [@bib19]) it is necessary to continue in the search of new natural or synthetic compounds that can act as free radical scavengers and help in the treatment or control of diseases related to oxidative stress.

Heterocyclic compounds, especially nitrogen heterocycles, are a very important class of compounds with application in the pharmaceutical industries, which comprise about 60% of all pharmacological substances. The tetrahydroquinoline (THQ) ring system, in particular, is a common structural motif found in numerous biologically active natural products showing broad biological activities ([@bib21]). Because of the significance of these scaffolds in drug discovery and medicinal chemistry, the development of new methodologies for the synthesis of THQs derivatives continues to be an active field of investigation, as is evidenced by the appearance of over 400 research articles in this area during the last years ([@bib27]; [@bib13]).

In the last decades, a great number of synthetic methods for access to THQs derivatives have been reported ([@bib27]). In many cases, these methodologies involve an intramolecular Friedel-Crafts reaction of *N*-substituted anilines with a suitable functional group bound to the nitrogen atom ([@bib2]). In this sense, the use of multicomponent Povarov reaction, catalyzed by Lewis or Brønsted acids between *N*-arylimines (obtained from anilines and aryl (alkyl)aldehydes) and electron-rich alkenes, is maybe the most powerful tool that provides quick and efficiently THQ scaffold with great structural diversity. Recently, we have been successfully exploring the cationic version of the Povarov reaction (a domino Mannich/Friedel-Crafts reaction). This method resulted highly efficient to access different N-derivatives of THQs ([@bib25]; [@bib3]), including the synthesis of new *N*-allyl/propargyl 1,2,3,4-THQs, promissory dual inhibitors against AChE and BChE enzymes ([@bib24]).

Diverse amine derivatives with the propargyl fragment in its structure are versatile compounds with demonstrated pharmacological and pharmaceutical applications such as antioxidant agents ([@bib8]) and as inhibitors of some monoamine oxidases MAO-B. Selegiline, Rasagiline, Pargyline, and Ladostigil drugs are widely used as enzymatic inhibitors in treatments of neurodegenerative diseases ([Fig. 1](#fig1){ref-type="fig"}) ([@bib4]; [@bib5]; [@bib18]). Taking into account all the above, in the present study, we report the synthesis, spectroscopic characterization and antioxidant activity of a new series of *N*-propargyl-THQs obtained via mild and expeditious InCl~3~ catalyzed-cationic Povarov reaction. Results indicated that some THQs derivatives evaluated showed good activity as potential free radical scavengers. In addition, theoretical studies of Molecular Quantum Similarity Measure allowed explaining the biological activity reported. Local reactivity descriptors like the local softness and electrophilicity indices were obtained with the help of Fukui function calculation.Fig. 1Propargylamines inhibitors of monoamine oxidases MAO-A and MAO-B.Fig. 1

2. Results and discussion {#sec2}
=========================

The preparation of new *N*-propargyl THQs **6a-g** via domino Mannich addition/Friedel-Crafts intramolecular alkylation reactions catalyzed by InCl~3~, was effective under mild condition reactions using N-propargylamines with formaline (37% in methanol) and *N*-vinylformamide as an electron-rich alkene. Acetonitrile (CH~3~CN) was used as solvent based on previous reports ([@bib25]; [@bib2]). Synthetic route and structures of final compounds are shown in [Scheme 1](#sch1){ref-type="fig"}. According to the results, although fluctuations in the reaction yield were shown, in general, the reaction showed to be powerful synthetic strategy to obtain the corresponding 1,2,3,4-THQ compounds with high structural diversification ([Table 1](#tbl1){ref-type="table"}).Scheme 1Synthesis of *N*-propargyl THQs 6a-g from *N-*propargylamines via domino Mannich/Friedel-Crafts alkylation reactions.Scheme 1Table 1Physicochemical parameters obtained for the new THQ compounds.Table 1CompoundRMW (g/mol)Time (h)Yield (%)m.p. (°C)[a](#tbl1fna){ref-type="table-fn"}**3a**H131.17351%Oil**3b**CH~3~145.20349%Oil**3c**OCH~3~161.20348%Oil**3d**CH~2~CH~3~159.23345%Oil**3e**Br210.07351%Oil**3f**Cl165.62344%Oil**3g**F149.16358%Oil**6a**H214.26451%118--120**6b**CH~3~228.29495%134--136**6c**OCH~3~244.29466%110--112**6d**CH~2~CH~3~242.32431%116--118**6e**Br293.16452%164--166**6f**Cl248.71423%158--160**6g**F232.25471%144--146[^1]

All new *N*-propargyl THQ derivatives **6a-g** were obtained as stable solids and were characterized by IR, ^1^H-NMR, ^13^C-NMR, and MS. In the IR spectra, C=O vibration bands (1643-1658 cm^−1^) and propargyl fragment vibration bands (3231-3279 cm^−1^) were observed. ^1^H NMR spectral analysis of the synthesized *N*-propargyl tetrahydroquinolines showed four groups of characterized signals. First, signals between 6.88-7.31 ppm indicated the presence of aromatic protons corresponding to the tetrahydroquinoline ring. Also was possible to observe the aliphatic proton signals, around 5.10--1.99 ppm, corresponding to THQ nucleus and the signal for the alkyne proton between 2.13--2.28 ppm. Finally, around 8.11--8.21 ppm, proton signal for formamide group was observed. This set of signals constitutes evidence that the formation of the tetrahydroquinoline compounds took place favorably. ^1^H and ^13^C nuclear magnetic resonance (NMR) spectra of compound **6a**-**6g** are included in supplementary material (Fig S1-FigS7).

The presence of a fragment *N*-propargyl in the new compounds is interesting owing to propargylamines are useful synthetic precursors in the obtaining of different organic substrates, natural products, and drugs as evidenced by the large number of articles published in the literature ([@bib10]; [@bib16]: [@bib30]). The versatility of propargylamines is due to its unique structure composed of an amine group in β-position to an alkyne moiety. Compounds with a carbon−carbon triple bond have characteristic reactivity and can behave as electrophilic substrates and as an electron source in nucleophilic reactions ([@bib18]). It is worth noting that, as mentioned above, some *N*-propargyl derivatives have been applied mainly as monoamine oxidase inhibitors (IMAO) and, according to the literature, could promote antioxidant effects by acting as radical scavengers ([@bib8]).

All compounds obtained were evaluated as antioxidant agents in presence of the stable radical DPPH (1,1-diphenyl-2-picrylhydrazyl) at a concentration ranging from 10 to 100 μL and compared with ascorbic acid as shown in [Table 2](#tbl2){ref-type="table"}. The DPPH scavenging activity varied greatly. There were no clear differences in IC~50~ values between the compounds synthesized despite the presence of substituents with different chemical properties and was not possible to observe an antioxidant effect compared with standard.Table 2% Decoloration of DPPH solution for synthesized compounds in comparation with ascorbic acid. Values are the average of triplicate experiments.Table 2Concentration (μg/mL)Compound1005010IC~50~**6a**12.63 ± 1.25.26 ± 1.51.04 ± 0.2\>100**6b**19.74 ± 3.210.52 ± 1.50.00 ± 0.0\>100**6c**45.53 ± 5.629.47 ± 4.121.05 ± 5.1\>100**6d**22.37 ± 2.416.58 ± 3.37.11 ± 2.0\>100**6e**22.63 ± 3.718.42 ± 2.56.58 ± 2.1\>100**6f**18.16 ± 5.57.89 ± 1.35.26 ± 1.2\>100**6g**20.00 ± 7.09.73 ± 0.82.8 ± 1.3\>100**Ascorbic acid**\-\--1 ± 0.3

On the other hand, [Table 3](#tbl3){ref-type="table"} showed that compounds **6b**, **6c**, **6d**, and **6g** have good activity in scavenging ABTS radical, presenting better IC~50~ values than those found for ascorbic acid, used as reference. This is consistent with the results reported previously where described compounds having an electron withdrawing group like fluorine, and electron donating groups, like methoxy on the phenyl rings, exhibit good antioxidant activity ([@bib20]; [@bib22]).Table 3ABTS radical scavenging activity (%) of the synthesized compounds, measured at 745 nm, compared to standard ascorbic acid. Values are the average of triplicate experiments.Table 3Concentration (μg/mL)Compound1005010IC~50~**6a**90.41 ± 8.775.27 ± 6.446.27 ± 2.112.30 ± 4.2**6b**98.08 ± 5.888.49 ± 6.679.32 ± 9.33.72 ± 0.7**6c**93.54 ± 7.591.68 ± 5.982.30 ± 5.42.12 ± 0.8**6d**94.03 ± 9.253.73 ± 5.078.46 ± 9.53.35 ± 0.5**6e**81.45 ± 6.268.88 ± 4.836.93 ± 8.641.15 ± 6.3**6f**86.31 ± 5.670.95 ± 6.66.85 ± 2.032.09 ± 2.5**6g**92.53 ± 8.782.99 ± 8.572.82 ± 6.52.98 ± 0.7**Ascorbic acid**\-\--35 ± 2.7

Computational methods are important tools to predict some compound properties with interesting experimental biological activities, e.g, QikProp is a quick, accurate, and easy to use absorption, distribution, metabolism, and excretion (ADME) prediction program ([@bib28]). The main parameters are shown in [Table 4](#tbl4){ref-type="table"}. Taking into account the Lipinski\'s rule of five (molecular weight below 500 Da, hydrogen bond donor less than 5, acceptor less than 10, and Log P (octanol/water partition coefficient) for the ligand less than five), the synthesized compounds did not present violations to this rule, being within of permissible range of each descriptor ([@bib17]). Likewise, the synthesized THQ series satisfies other parameters involved in the absorption, distribution and membrane penetration as water solubility (Log S) and polar surface area (PSA). Finally, the predicted qualitative oral absorption was calculated. This prediction is made through the analysis of the appropriate values of different descriptors. The analysis showed that the compounds could present good oral absorption. In general, the new *N*-propargyl tetrahydroquinolines presented permissible values in the different descriptors calculated ([@bib26]).Table 4Computer aided ADME screening of the synthesized compounds *N*-propargyl tetrahydroquinolines.Table 4CompoundM.W. (g/mol)Log P (o/w)[a](#tbl4fna){ref-type="table-fn"}donors HB[b](#tbl4fnb){ref-type="table-fn"}acceptors HB[c](#tbl4fnc){ref-type="table-fn"}Log S[d](#tbl4fnd){ref-type="table-fn"}PSA[e](#tbl4fne){ref-type="table-fn"}Human Oral Absorption[f](#tbl4fnf){ref-type="table-fn"}**6a**214.2661.6281.5003.500−1.82751.6573**6b**228.2931.8821.5003.500−2.03051.8573**6c**244.2931.6971.5004.250−1.75060.1033**6d**242.3202.2301.5003.500−2.39851.8783**6e**293.1622.0681.5003.500−2.22550.6923**6f**248.7112.0681.5003.500−2.20551.8583**6g**232.2571.7251.5003.500−1.71050.7263[^2][^3][^4][^5][^6][^7]

To understand the biological activity reported, an analysis of chemical reactivity were developed and Quantum Similarity field and Chemical reactivity framework were used. Taking into account the structural features of these molecular sets, which have only a substitute, the molecular quantum similarity indices allowed us to quantify the structural and electronic effects from a local point of view. The highest overlap similarity was observed between **6e** and **6b** and for **6d** and **6f** with a value of 0.9998 in both cases ([Table 5](#tbl5){ref-type="table"}), with a Euclidean distance of 1.3725 and 0.7756 respectively ([Table 6](#tbl6){ref-type="table"}).Table 5Molecular quantum Similarity values using the overlap operator.Table 56a6b6c6d6e6f6g**6a**1.0000**6b**0.99541.0000**6c**0.98970.99851.0000**6d**0.98950.99580.99351.0000**6e**0.99570.99980.99580.99641.0000**6f**0.99130.99950.99580.99980.99931.0000**6g**0.99150.99780.99320.99520.99590.99641.0000Table 6Molecular Quantum Similarity values using the Euclidean distance for the overlap operator.Table 66a6b6c6d6e6f6g**6a**0.0000**6b**4.17210.0000**6c**7.95654.54850.0000**6d**7.40874.15152.24230.0000**6e**3.99581.37254.80284.21610.0000**6f**4.25461.54584.25350.77563.54100.0000**6g**5.32272.87504.60775.18833.56653.06000.0000

The most active compound **6c** has a high overlap similarity value with the compounds **6b** (0.9985), **6e** and **6f** (0.9985), with euclidean distances of 4.5485, 4.8028 and 4.2535 respectively. Compound **6c** also has a high electronic similarity with the compounds **6d** (0.9709), **6e** (0.9417), **6f** (0.9512), **6g** (0.9589) (See Table S1**,** supporting information) with euclidean distances of 0.9481, 1.3324, 1.2288, 1.1379, respectively (See Table S2, supporting information). These compounds **6e**, **6f**, and **6g** have strong electron withdrawing groups such as --Br, -Cl and --F compared with compound **6c** which has a methoxy group. In general, the electronic similarity values are higher than the Overlap similarity values. For this reason, chemical reactivity descriptors are reported in [Table 7](#tbl7){ref-type="table"}.Table 7Global reactivity descriptors for the compounds.Table 7CompoundC. Potential (μ, eV)C. Hardness (ɳ,eV)Softness (S, eV)^−1^Electrophilicity (ω, eV)**6a**-3.52337.88420.12680.7873**6b**-3.36527.55480.28380.7494**6c**-3.28567.22530.30430.7470**6d**-3.34567.65280.29890.7313**6e**-3.64837.35990.27410.9042**6f**-3.65517.39850.27350.9028**6g**-3.60857.39560.27710.8803

The higher chemical potential is shown for the compound **6f** (μ = -3.6551 eV), hardness (ɳ = 7.3985 eV), softness (S = 0.2735 eV^−1^) and electrophilicity (ω = 0.9028 eV). The most reactive compound **6c** has chemical potential (μ = -3.2856), hardness (ɳ = 7.2253 eV), softness (S = 0.3043 eV^−1^) and electrophilicity (ω = 0.7470 eV). These reactivity parameters of new compounds can be related to the properties as free radical scavengers.

[Fig. 2](#fig2){ref-type="fig"} shows the Fukui Function$\left\langle f_{k}^{-} \right\rangle \approx \left| {HOMO} \right|^{2}$ and$\left\langle f_{k}^{+} \right\rangle \approx \left| {LUMO} \right|^{2}$figures for the selected compound **6c** (most active compound, **3a** and **6a** (reference compound to series **3** and **6** respectively).Fig. 2Fukui Funtions$\left\langle f_{k}^{-} \right\rangle \approx \left| {HOMO} \right|^{2}$and$\left\langle f_{k}^{+} \right\rangle \approx \left| {LUMO} \right|^{2}$, for the compound selected **6c** (most active compound), **6a** and **3a** (reference compounds to series **6** and precursors **3** respectively).Fig. 2

Compounds **3a** and **6a** have the same reactivity maps in both figures. These reactivity maps can be related to the retrodonor process on the non-covalent interaction for these compounds ([@bib29]; [@bib11]). Unlike the reference compounds, the most active compound **6c** has different maps for the Fukui Functions$\left\langle f_{k}^{-} \right\rangle \approx \left| {HOMO} \right|^{2}$and$\left\langle f_{k}^{+} \right\rangle \approx \left| {LUMO} \right|^{2}$ respectively. Therefore, the compound **6c** has zones good defined for electrophilic and nucleophilic attacks that can influence their activity. Finally, the local electrophilicity and nucleophilicity dissimilarity using DFT Based Reactivity Descriptors, to relate the chemical reactivity with the quantum similarity, are shown in [Table 8](#tbl8){ref-type="table"}. The compound **6c** has the higher local reactivity similarity (electrophilicity dissimilarity: 0.041), and the compound **6d** has the higher nucleophilicity dissimilarity: 5.52 × 10^−3^ with respect to the reference compound **6a**. Theses dissimilarities can be related to the zone of reactivity (the Fukui function maps, see [Fig. 2](#fig2){ref-type="fig"}) in this series of compounds.Table 8Local electrophilicity and nucleophilicity dissimilarity.Table 8Reference Compound (6a) vsElectrophilicity dissimilarityNucleophilicity dissimilarity**6b**7.51 × 10^−3^4.09 × 10^−3^**6c**0.0414.91 × 10^−3^**6d**9.89 × 10^−3^5.52 × 10^−3^**6e**3.35 × 10^−3^1.19 × 10^−3^**6f**5.22 × 10^−3^4.28 × 10^−4^**6g**4.29 × 10^−3^2.79 × 10^−3^

3. Experimental {#sec3}
===============

3.1. Chemistry {#sec3.1}
--------------

All reagents were purchased from either Merck (Darmstadt, Germany) or Sigma and Aldrich Chemical Co (St. Louis, MO, USA) and used without further purification. All products were characterized by spectral data (IR, MS, ^1^H-NMR, ^13^C-NMR). NMR spectra (^1^H and ^13^C) were measured on a Bruker Ultrashield-400 spectrometer (Rheinstetten, Germany), using CDCl~3~ as solvent and reference. *J* values are reported in Hz; chemical shifts are reported in ppm (δ) relative to the solvent peak (residual CHCl~3~ in CDCl~3~ at 7.26 ppm for protons and 77 ppm for carbon atoms). Signals were designated as follows: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; td, triplet of doublets; q, quartet; m, multiplet, and br., broad. IR spectra (KBr pellets, 500--4000 cm^−1^) were recorded on a NEXUS 670 FT-IR spectrophotometer (Thermo Nicolet, Madison, WI, USA). GC-MS analyses were performed on a model Trace 1300 GC-MS instrument (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a Rtx-5MS on-column auto-injector and a fused silica capillary column (DB-5, 30 m ˆ 0.25 mm ID, 0.25 μm film thickness). MS were recorded in electron ionization (EI) mode, with the energy of 70 eV. The ion source temperature was 200 °C; 4.00 min solvent cut time. Melting points (uncorrected) were measured on an Electrothermal IA9100 melting point apparatus (Stone, Staffs, UK). The reaction progress was monitored using thin layer chromatography on PF254 TLC aluminum sheets from Merck. Column chromatography was performed using Silica gel (60--120 mesh) and Solvents employed were of analytical grade.

3.2. General procedure for the synthesis of N-propargyl-1,2,3,4-THQs {#sec3.2}
--------------------------------------------------------------------

THQ derivatives were efficiently synthesized according to methodology reported previously ([@bib24]), the protocol outlined in [Fig. 1](#fig1){ref-type="fig"}. This protocol can be divided into two steps:

### 3.2.1. Step 1: preparation of *N*-propargylamine {#sec3.2.1}

In a round-bottomed flask, a 5-mL solution in anhydrous DMF of the corresponding anilines **1** (1.8 mmol), potassium iodide (0.1 mmol) and anhydrous sodium carbonate (2 mmol) was prepared and stirred constantly at 0 °C. A solution of propargyl bromide **2** (1.0 mmol) in anhydrous DMF was added dropwise and the mixture was kept at 0 °C for 20 minutes. The reaction was allowed to stir at room temperature for 3--4 h, indicated on TLC. The reaction mixture was diluted with water and extracted with ethyl acetate (3 × 20 mL), the organic phase was separated and dried (Na~2~SO~4~), the solvent removed under vacuum and the resulting product was purified by column chromatography on silica gel, (petroleum ether: ethyl acetate) to obtain the pure *N*-propargyl anilines **3a-g**.

### 3.2.2. Step 2: preparation of *N*-propargyl THQs {#sec3.2.2}

All the reactions were performed at room temperature. In a round bottom flask, a 5 mL solution in CH~3~CN of preformed *N*-propargylaniline **3a-g** (1.0 mmol) and formaldehyde (37% in methanol) **4** (1.1 mmol) was prepared and stirred for 10 minutes. 5 mL solution of InCl~3~ (20% mol) in CH~3~CN was then added. After 20 minutes a solution of *N-*vinylformamide **5** (1.1 mmol) in CH~3~CN was incorporated to the reaction mixture and was vigorously stirred. The resulting mixture was stirred for 3--4 h. After the workup, the final product was purified by column chromatography, eluted with the appropriate mixture of petroleum ether and ethyl acetate to afford pure THQs **6a-g**.

### 3.2.3. N-(1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6a)** {#sec3.2.3}

Coffee solid; m.p. 118--120 °C; Yield 51%; **IR**: 3279, 3038, 2958, 2922, 2847, 1658, 1492, 751; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.20 (1H, s), 7.22--7.31 (2H, m), 6.82--6.88 (2H, m), 5.21--5.28 (1H, m), 4.19--4.26 (1H, dd, *J* = 18.2, 1.7 Hz), 4.00--4.07 (1H, dd, *J* = 18.2, 1.1 Hz), 3.32--3.39 (2H, m), 2.25--2.28 (1H, s), 2.15--2.24 (2H, m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm):160.09, 144.57, 129.60, 129.17, 122.23, 118.11, 112.81, 79.01, 72.09, 45.24, 44.76, 40.72, 28.48; **GC-MS m/z (rel. int. %):** 213.80 (24), 174.88 (10), 167.78 (100), 129.88 (20). *Anal. Calc. for* C~13~H~14~N~2~O: 214.11 uma.

### 3.2.4. N-(6-methyl-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6b)** {#sec3.2.4}

Orange solid; m.p. 134--136 °C; Yield 95%; **IR**: 3278, 2951, 2923, 2854, 1655, 1506, 1380, 1328, 1230, 803; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.18 (1H, s), 6.97--7.05 (2H, m), 6.70 (1H, d, *J* = 8.3 Hz), 5.16 (1H, d, *J* = 6.1 Hz), 4.09--4.16 (1H, d, *J* = 18.1 Hz), 3.88--3.95 (1H, d, *J* = 18.1 Hz), 3.21--3.26 (2H, m), 2.22--2.24 (3H, s), 2.15 (1H, br), 1.99--2.14 (2H, m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.04, 142.37, 130.11, 129.74, 127.53, 122.40, 113.11, 79.08, 72.08, 45.34, 44.66, 40.86, 28.75, 20.23; **GC-MS m/z (rel. int. %):** 227.71 (38), 188.92 (10), 181.88 (100), 166.87 (12), 143.97 (24). *Anal. Calc. for* C~14~H~16~N~2~O: 228.13 uma.

### 3.2.5. N-(6-methoxy-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6c)** {#sec3.2.5}

Coffee solid; m.p. 110--112 °C; Yield 66%; **IR**: 3262, 3231, 2953, 2917, 2845, 1653, 1501, 1460, 1374, 1048, 737; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.18 (1H, s), 6.80 (1H, dd, *J* = 8.9, 3.0 Hz), 6.71--6.76 (2H, m), 5.17 (1H, dd, *J* = 12.9, 5.1 Hz), 4.10 (1H, dd, *J* = 18.1, 2.2 Hz), 3.90 (1H, dd, *J* = 18.1, 2.3 Hz), 3.73 (3H, s), 3.18--3.22 (2H, m), 2.13--2.15 (1H, br), 2.04--2.23 (2H, m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.05, 152.33, 138.91, 123.74, 115.25, 114.57, 114.51, 79.11, 72.20, 55.71, 45.55, 44.85, 41.22, 28.94; **GC-MS m/z (rel. int. %):** 243.76 (80), 204.89 (12), 197.97 (100), 159.64 (28), 144.80 (16). *Anal. Calc. for* C~14~H~16~N~2~O~2~: 244.12 uma.

### 3.2.6. N-(6-ethyl-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6d)** {#sec3.2.6}

Beige solid; m.p. 116--118 °C; Yield 31%; **IR**: 3273, 3231, 2951, 2923, 2849, 1648, 1506, 1376, 1331, 804; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.11 (1H, s), 7.03 (1H, d, *J* = 8.1 Hz), 6.97 (1H, d, *J* = 14.5 Hz), 6.71 (1H, d, *J* = 8.4 Hz), 5.10--5.17 (1H, m), 4.11 (1H, d, *J* = 18.1 Hz), 3.91 (1H, d, *J* = 18.1 Hz), 3,18--33.26 (2H, m), 2.52 (2H, q, *J* = 7.5 Hz), 2.15 (1H, t, *J* = 6.6 Hz), 2.03--2.13 (2H, m), 1.18 (3H, t, *J* = 7.6 Hz). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.15, 142.56, 133.99, 128.94, 128.50, 122.32, 113.02, 79.19, 72.11, 45.32, 44.70, 40.83, 28.74, 27.74, 15.74; **GC-MS m/z (rel. int. %):** 242.03 (34), 195.93 (100), 181.81 (12), 157.78 (22). *Anal. Calc. for* C~15~H~18~N~2~O: 242.14 uma.

### 3.2.7. N-(6-bromo-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6e)** {#sec3.2.7}

White solid; m.p. 164--166 °C; Yield 52%; **IR**: 3239, 3044, 2956, 2920, 2851, 1645, 1490, 1241, 891; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.19 (1H, s), 7.21--7.25 (2H, m), 6.62 (1H, d, *J* = 9.1 Hz), 5.15 (1H, dd, *J* = 11.4, 5.1 Hz)**,** 4.07 (1H, d, *J* = 18.3 Hz**)**, 3.91 (1H, d, *J***=** 18.2 Hz), 3.26 (2H, t, *J***=** 5.6 Hz**)**, 2.13--2.17 (1H, br), 1.99--2.13 (2H, m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.85, 143.81, 131.33, 131.03, 125.38, 114.35, 109.09, 78.92, 72.90, 45.90, 43.78, 40.71, 28.59; **GC-MS m/z (rel. int. %):** 291.52 (40), 247.98 (100), 209.76 (28), 166.82 (62). *Anal. Calc. for* C~13~H~13~BrN~2~O: 292.02 uma.

### 3.2.8. N-(6-chloro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6f)** {#sec3.2.8}

Beige solid; m.p. 158--160 °C; Yield 23%; **IR**: 3231, 2949, 2914, 2842, 1643, 1494, 1387, 1331, 1238; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.21 (1H, s); 7.11--7.16 (2H, m), 6.69 (1H, d, *J* = 9.0 Hz), 5.14--5.20 (1H, m), 4.10 (1H, d, *J* = 18.2 Hz), 3.94 (1H, d, *J* = 18.3 Hz), 3.20--3.25 (2H, m), 2.15--2.18 (1H, br), 2.02--2.15 (2H, m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.09, 143.15, 129.19, 128.95, 123.86, 122.84, 114.16, 78.50, 72.37, 45.43, 44.48, 40.86, 28.43; **GC-MS m/z (rel. int. %):** 247.78 (44), 208.85 (15), 201.64 (100), 166.90 (40). *Anal. Calc. for* C~13~H~13~ClN~2~O: 248.07 uma.

### 3.2.9. N-(6-fluoro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide **(6g)** {#sec3.2.9}

Beige solid; m.p. 144--146 °C; Yield 71%; **IR**: 3273, 3257, 2954, 2915, 1650, 1503, 801; ^**1**^**H NMR** (400 MHz, CDCl~3~) δ (ppm): 8.19 (1H, s), 6.88--6.93 (2H, m), 6.67--6.73 (1H, m), 5.17 (1H, dd, *J* = 13.2, 5.4 Hz), 4.08 (1H, dd, *J* = 18.2, 2.2 Hz), 3.93 (1H, dd, *J* = 18.2, 2.2 Hz), 3.21--3.26 (2H, m), 2.15--2.17 (1H, br), 1.99--2.20 (2H. m). ^**13**^**C NMR** (100 MHz, CDCl~3~) δ (ppm): 160.14, 141.04, 123.94, 115.78, 115.56, 114.13, 114.06, 78.74, 72.34, 45.67, 44.60, 41.16, 28.72; **GC-MS m/z (rel. int. %):** 231.80 (28), 192.85 (10), 185.78 (100), 147.74 (30). *Anal. Calc. for* C~13~H~13~FN~2~O: 232.10 uma.

3.3. Measurement of DPPH radical scavenging activity {#sec3.3}
----------------------------------------------------

DPPH is a stable free radical that can accept an electron or hydrogen radical to become a stable molecule. The antioxidant activity can be observed by a change of coloration deep violet to yellow in the mixture of compounds with a methanolic solution of DPPH. The hydrogen atom or electron donation ability of the compounds was measured from the bleaching of the purple colored methanol solution of DPPH ([@bib14]).

The free radical scavenging effect of the compounds was assessed by the discoloration of a methanolic solution of DPPH as previously reported ([@bib22]). Tetrahydroquinolines **6a**-**g** was assayed at 100, 50 and 10 μg/mL. The scavenging of free radicals by THQs was evaluated spectrophotometrically at 517 nm against the absorbance of the DPPH radical. The percentage of discoloration was calculated as follows:Where AE, is the absorbance of the solution after adding the extract and AD is the absorbance of the blank DPPH solution. Ascorbic acid was used as reference compounds, with IC~50~ value of 1 μg/mL.

3.4. Measurement of ABTS radical scavenging activity {#sec3.4}
----------------------------------------------------

The ABTS (2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging assay is a rapid and efficient method, based on the ability of the hydrogen donating antioxidants to scavenge the long-life radical cation ABTS^•+^. In this method, the preformed radical monocation of ABTS is generated by the oxidation of ABTS with potassium persulfate and is reduced in the presence of such hydrogen donating antioxidants ([@bib12]).

ABTS assay was performed according to the protocol ([@bib22]; [@bib23]). The ABTS radical cation (ABTS^•+^) was produced by reaction of 7 mM stock solution of ABTS with 2.45 mM potassium persulfate and allowing the mixture to stand in dark at room temperature for 12 h before use. The ABTS^•+^ solution was diluted with methanol to give an absorbance of 0.7 ± 0.01 at 745 nm. Compounds (1 mL) were allowed to react with 2 ml of the ABTS^•+^ solution and the absorbance was measured at 745 nm after 1 min. Data for each assay was recorded in triplicate. Ascorbic acid was used as positive controls with IC~50~ value of 35 μg/mL. The scavenging activity was estimated based on the percentage of ABTS radicals scavenged by the following formula:Where A0 is the absorption of control, AS is the absorption of a tested compound solution.

3.5. In silico prediction of pharmacokinetic properties {#sec3.5}
-------------------------------------------------------

Pharmacokinetic properties of THQ compounds were calculated an *in silico* way through ADME descriptors using QikProp ([@bib7]). Based on the Lipinski\'s rule of 5, some of the descriptors predicted were molecular weight, Van der Waals, surface areas of polar nitrogen and oxygen atoms, H bond acceptors, H bond donors, Log P (octanol/water) and aqueous solubility ([@bib17]), proposing a first analysis of the newly synthesized compounds as drug-likeness.

3.6. Computational methods {#sec3.6}
--------------------------

The theoretical study was realized based on Molecular Quantum Similarity Measure (MQSM), density functions, analyzing a series of reactive descriptors as chemical hardness (η), chemical potential (μ), electrophilicity index (ω), softness(s), and Fukui functions. All the structures included in this study were optimized at B3LYP/6-31G(d) level of theory by using the Gaussian 09 package ([@bib9]). Detail and basis of the methods used are included in the supplementary material.

4. Conclusion {#sec4}
=============

In summary, the synthesis of a new series of substituted *N*-propargylTHQs derivatives has been developed in mild conditions and simple procedure through the Domino Mannich/Friedel - Crafts reactions using InCl~3~ as catalyst. The antioxidant activity is dependent on the concentration of the compounds, likewise, the compound **6c** and **6g** (with methoxy and fluorine group on the aromatic ring respectively) presented the most favorable antioxidant activity values. Physicochemical descriptors, calculated theoretically, indicated that the new compounds have a low toxicity risk. Structurally the *N*-propargyl THQs are attractive for the production of a second generation of compounds due to the reactivity of the propargyl fragment. In this study, we obtained compounds with higher antioxidant capacity than the reference compound. From the theoretical calculations (MQSM, Global reactivity descriptors, and Fukui Functions), we can establish similarity and discriminate different reactive sites in the new molecules where the oxidative process occurs. These sites can be used for the design of new compounds with interesting biological activity.
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[^1]: Uncorrected.

[^2]: log *P* for octanol/water (−2.0 -- −6.5).

[^3]: Estimated number of H-bonds that would be donated by the solute to water molecules in an aqueous solution.

[^4]: Estimated number of H-bonds that would be accepted by solute from water molecules in an aqueous solution.

[^5]: Predicted aqueous solubility, log *S, S* in mol dm^−3^ (−6.5 -- 0.5).

[^6]: Van der Waals surface areas of polar nitrogen and oxygen atoms.

[^7]: Qualitative human oral absorption predicted: 1, 2 or 3 for low, medium or high.
